Atrial Septal Defect Device Closure in Patients with Metabolic Diseases or Genetic Syndromes

Abstract

Concomitant metabolic or genetic syndromes can make atrial septal defect device closure difficult. We searched our database and found eight. The cohort consists of patients with different metabolic and genetic disease . Thromboembolic events and device embolization occurred in some patients. Careful attention is recommended in patients with special diseases.